Ketamine for the treatment of depression: what about the addictive potential?
Hillemacher
Thomas
T
Bleich
Stefan
S
Demling
Joachim
J
Kornhuber
Johannes
J
D000778:Anesthetics, Dissociative / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D007649:Ketamine / Q000009:adverse effects* / Q000627:therapeutic use; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000209:etiology*; D013618:Tachyphylaxis; D016896:Treatment Outcome
D000778:Anesthetics, Dissociative; D007649:Ketamine; D016194:Receptors, N-Methyl-D-Aspartate